share_log

Sarepta Therapeutics analyst ratings

Benzinga Analyst Ratings ·  Oct 15, 2021 07:50
DateResearch FirmActionCurrentPT
10/15/21Credit SuisseMaintainsNeutral95.0
10/12/21Credit SuisseMaintainsNeutral100.0
10/12/21BTIGMaintainsBuy125.0
9/15/21GuggenheimUpgradesBuy
8/16/21Morgan StanleyMaintainsEqual-Weight90.0
8/05/21Credit SuisseMaintainsNeutral75.0
8/05/21JP MorganUpgradesNeutral87.0
6/15/21BTIGInitiates Coverage OnBuy110.0
4/19/21Morgan StanleyMaintainsEqual-Weight93.0
3/02/21SVB LeerinkMaintainsOutperform126.0
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment